Concorde Asset Management LLC Purchases 13,002 Shares of Medical Properties Trust, Inc. (NYSE:MPW)

Concorde Asset Management LLC grew its position in Medical Properties Trust, Inc. (NYSE:MPW) by 24.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 66,702 shares of the real estate investment trust’s stock after purchasing an additional 13,002 shares during the quarter. Concorde Asset Management LLC’s holdings in Medical Properties Trust were worth $287,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Lindbrook Capital LLC raised its stake in Medical Properties Trust by 112.1% in the first quarter. Lindbrook Capital LLC now owns 7,225 shares of the real estate investment trust’s stock valued at $34,000 after buying an additional 3,819 shares during the last quarter. Versant Capital Management Inc grew its position in Medical Properties Trust by 435.0% during the 2nd quarter. Versant Capital Management Inc now owns 7,972 shares of the real estate investment trust’s stock worth $34,000 after purchasing an additional 6,482 shares during the last quarter. Iron Horse Wealth Management LLC increased its stake in Medical Properties Trust by 166.7% during the 2nd quarter. Iron Horse Wealth Management LLC now owns 8,000 shares of the real estate investment trust’s stock valued at $34,000 after purchasing an additional 5,000 shares in the last quarter. Future Financial Wealth Managment LLC purchased a new position in shares of Medical Properties Trust in the first quarter worth $38,000. Finally, Fidelis Capital Partners LLC acquired a new stake in shares of Medical Properties Trust during the first quarter worth $43,000. 71.79% of the stock is owned by institutional investors and hedge funds.

Medical Properties Trust Stock Performance

NYSE:MPW opened at $5.94 on Thursday. The company has a debt-to-equity ratio of 1.51, a quick ratio of 2.93 and a current ratio of 2.93. The stock has a market capitalization of $3.56 billion, a PE ratio of -2.68, a P/E/G ratio of 0.68 and a beta of 1.28. Medical Properties Trust, Inc. has a fifty-two week low of $2.92 and a fifty-two week high of $6.55. The company has a fifty day moving average of $4.88 and a two-hundred day moving average of $4.73.

Medical Properties Trust (NYSE:MPW) last released its quarterly earnings results on Thursday, August 8th. The real estate investment trust reported ($0.54) earnings per share for the quarter, missing the consensus estimate of $0.21 by ($0.75). The company had revenue of $266.60 million for the quarter, compared to analysts’ expectations of $259.53 million. During the same period in the previous year, the business posted $0.48 EPS. The firm’s revenue was down 21.0% on a year-over-year basis. As a group, research analysts forecast that Medical Properties Trust, Inc. will post 0.89 earnings per share for the current fiscal year.

Medical Properties Trust Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 10th. Investors of record on Monday, September 9th will be paid a $0.08 dividend. This represents a $0.32 annualized dividend and a yield of 5.39%. The ex-dividend date of this dividend is Monday, September 9th. Medical Properties Trust’s dividend payout ratio is currently -14.41%.

Insider Buying and Selling at Medical Properties Trust

In other news, Director C Reynolds Thompson III sold 20,530 shares of the company’s stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $4.38, for a total transaction of $89,921.40. Following the completion of the sale, the director now owns 54,637 shares of the company’s stock, valued at $239,310.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, Director C Reynolds Thompson III sold 20,530 shares of the business’s stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $4.38, for a total transaction of $89,921.40. Following the transaction, the director now directly owns 54,637 shares in the company, valued at approximately $239,310.06. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Elizabeth N. Pitman sold 10,025 shares of the stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $4.98, for a total value of $49,924.50. Following the completion of the sale, the director now directly owns 68,653 shares of the company’s stock, valued at approximately $341,891.94. The disclosure for this sale can be found here. 1.53% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. BNP Paribas lowered Medical Properties Trust from an “outperform” rating to a “neutral” rating and reduced their target price for the stock from $6.00 to $4.00 in a research note on Tuesday, July 2nd. Colliers Securities raised Medical Properties Trust from a “neutral” rating to a “buy” rating and set a $6.50 target price for the company in a report on Friday, September 13th. Finally, Truist Financial increased their price target on shares of Medical Properties Trust from $5.00 to $6.00 and gave the stock a “hold” rating in a report on Friday, September 13th. Three analysts have rated the stock with a sell rating, seven have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, Medical Properties Trust presently has a consensus rating of “Hold” and an average price target of $5.22.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.